This report titled precision medicine market studies various technology type, application type and geographical scenario. In July 2021, The White House announced that it is giving out USD 55.0 million to a collection of hospitals and companies to uncover links between a person’s genome and disease and built a genetic database of initially at least 1 million Americans. Market experts suggest that the proposed initiative has two main components: a near-term focus on cancers and a longer-term aim to generate knowledge applicable to the whole range of health and disease. Both components are now within the reach because of advances in basic research, including molecular biology, genomics, and bioinformatics.
For the purpose of this study, the global precision medicine market on the basis of technology type is segmented into companion diagnostics, gene sequencing, drug discovery, big data analytics, bio informatics & 3D printing. Market size estimates and forecast for these segments for the period 2019 to 2029 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2021 to 2029, considering 2020 as the base year.
For the purpose of this study, the global precision medicine market on the basis of application type is segmented into oncology, cardiovascular diseases, central nervous system, infectious diseases & others. Market size estimates and forecast for these segments for the period 2019 to 2029 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2021 to 2029, considering 2020 as the base year.
The precision medicine market has been geographically categorized into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, Brazil, and GCC countries. Market size and forecast for these segments during 2019 to 2029 and their CAGRs for the period 2021 to 2029 are provided in this report.
The major key players profiled in the precision medicine market are on the basis of various characteristics such as business description, financial health and budget allocation, product portfolio, and news coverage. The key players profiled in this report are Biocrates Life Sciences, Nanostring Technologies, Tepnel Pharma Services, Intomics, Ferrer InCode, Abbott Laboratories, Almac Group, Ltd., bioMérieux SA, Covance, Silicon Biosystems (now part of the Menarini Group), Pfizer, Eagle Genomics, Source Precision Medicine, Inc., Laboratory Corporation of America Holdings, Medtronics, Novartis, Qiagen, Quest Diagnostics, Roche Holding, Teva Pharmaceuticals, and others.
This product will be delivered within 2 business days.
For the purpose of this study, the global precision medicine market on the basis of technology type is segmented into companion diagnostics, gene sequencing, drug discovery, big data analytics, bio informatics & 3D printing. Market size estimates and forecast for these segments for the period 2019 to 2029 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2021 to 2029, considering 2020 as the base year.
For the purpose of this study, the global precision medicine market on the basis of application type is segmented into oncology, cardiovascular diseases, central nervous system, infectious diseases & others. Market size estimates and forecast for these segments for the period 2019 to 2029 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2021 to 2029, considering 2020 as the base year.
The precision medicine market has been geographically categorized into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, Brazil, and GCC countries. Market size and forecast for these segments during 2019 to 2029 and their CAGRs for the period 2021 to 2029 are provided in this report.
The major key players profiled in the precision medicine market are on the basis of various characteristics such as business description, financial health and budget allocation, product portfolio, and news coverage. The key players profiled in this report are Biocrates Life Sciences, Nanostring Technologies, Tepnel Pharma Services, Intomics, Ferrer InCode, Abbott Laboratories, Almac Group, Ltd., bioMérieux SA, Covance, Silicon Biosystems (now part of the Menarini Group), Pfizer, Eagle Genomics, Source Precision Medicine, Inc., Laboratory Corporation of America Holdings, Medtronics, Novartis, Qiagen, Quest Diagnostics, Roche Holding, Teva Pharmaceuticals, and others.
This product will be delivered within 2 business days.
Table of Contents
Chapter 1 Preface 10
Chapter 2 Executive Summary 15
Chapter 3 Global Precision Medicine Market Overview 20
Chapter 4 Global Precision Medicine Market Analysis, By Technology Type 27
Chapter 5 Global Precision Medicine Market Analysis, By Applications 37
Chapter 6 Global Precision Medicine ion Market, By Geography 42
Chapter 7 Company Profiles 51
Companies Mentioned
- Biocrates Life Sciences
- Nanostring Technologies
- Tepnel Pharma Services
- Intomics
- Ferrer InCode
- Abbott Laboratories
- Almac Group Ltd.
- bioMérieux SA
- Covance
- Silicon Biosystems (now part of the Menarini Group)
- Pfizer
- Eagle Genomics
- Source Precision Medicine Inc.
- Laboratory Corporation of America Holdings
- Medtronics
- Novartis
- Qiagen
- Quest Diagnostics
- Roche Holding
- Teva Pharmaceuticals
